AACR Disparities Meeting: Finding Solutions to Diversify Clinical Trials
“If our patients are diverse, why are clinical trials so white?” Vanessa Sheppard, PhD, invoked this quote from author and...
“If our patients are diverse, why are clinical trials so white?” Vanessa Sheppard, PhD, invoked this quote from author and...
Due to advances in screening and treatment, the survival rate for patients with breast cancer has increased in recent decades. However, this progress...
Once considered undruggable, mutant KRAS has emerged in recent years as a viable target for anticancer therapeutics. As a...
Cancer is often described as a disease of old age, but over 15,000 children are diagnosed with cancer each...
What if a machine could “think” like a doctor and diagnose and treat a disease? This is one of the long-term goals for the...
This year marks the 10th anniversary of Cancer Discovery, a journal of the AACR. To celebrate the anniversary, Cancer Discovery published a special anniversary issue, featured spotlights on groundbreaking articles on its website, and held the Cancer Discovery ...
Ten years ago, then-President of the AACR, Tyler Jacks, PhD, FAACR, conceived the idea for a “comprehensive, high-impact journal that would present new...
They say age is just a number, but when it comes to cancer, getting older substantially increases your risk....
You’re working away on your latest project when your stomach suddenly growls. Stepping away from your desk, you head...
Since 2014, the American Association for Cancer Research (AACR) has invited early-career investigators to apply to the NextGen Stars program, which provides awardees the opportunity to present their...